Profile data is unavailable for this security.
About the company
Biosenic SA formerly known as Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. It also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).
- Revenue in EUR (TTM)0.00
- Net income in EUR-19.67m
- Incorporated2006
- Employees12.00
- LocationBiosenic SARue Granbonpre 11, Batiment H (bte 24)MONT-SAINT-GUIBERT 1435BelgiumBEL
- Phone+32 493097366
- Fax+32 71121001
- Websitehttp://www.bonetherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inno-Gene SA | 261.22k | -337.88k | 2.24m | 27.00 | -- | 1.47 | -- | 8.59 | -0.2559 | -0.2559 | 0.1979 | 1.16 | 0.1086 | 4.67 | 0.673 | -- | -14.04 | 7.92 | -19.07 | 10.73 | 39.18 | 73.63 | -129.34 | 11.59 | 2.58 | -- | 0.0362 | -- | -93.08 | -16.73 | -542.12 | -- | -- | -- |
| ReNeuron Group Plc | 290.84k | -5.93m | 2.25m | 34.00 | -- | 0.7966 | -- | 7.75 | -0.0888 | -0.0888 | 0.0044 | 0.0424 | 0.0246 | -- | 0.6442 | 7,323.53 | -50.10 | -43.12 | -101.09 | -58.50 | -- | -- | -2,037.35 | -714.73 | -- | -- | 0.1247 | -- | 31.51 | 65.26 | 44.18 | -- | -1.31 | -- |
| N4 Pharma PLC | 2.28k | -1.49m | 2.43m | 5.00 | -- | 1.85 | -- | 1,068.23 | -0.0053 | -0.0053 | 0.00001 | 0.0042 | 0.0011 | -- | 0.009 | 390.00 | -74.20 | -57.05 | -79.41 | -61.13 | -- | -- | -65,475.90 | -309,312.80 | -- | -- | 0.00 | -- | -- | -51.52 | -24.05 | -- | -- | -- |
| bioXXmed AG | 20.51k | -660.70k | 2.51m | 1.00 | -- | 0.1188 | -- | 122.24 | -0.1286 | -0.1286 | 0.004 | 4.11 | 0.0009 | -- | 0.4423 | 20,510.00 | -3.02 | -10.26 | -3.06 | -10.75 | -- | -- | -3,221.36 | -7,303.55 | -- | -- | 0.00 | -- | -72.60 | -32.89 | 79.56 | -- | -- | -- |
| Fluicell AB | 285.75k | -2.27m | 2.64m | 17.00 | -- | 25.89 | -- | 9.25 | -0.2201 | -0.2201 | 0.0282 | 0.0036 | 0.1624 | 0.6813 | 3.84 | 196,352.90 | -129.20 | -87.55 | -222.48 | -126.02 | 52.07 | 72.97 | -795.51 | -650.23 | 0.5001 | -- | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
| Gabather AB | 0.00 | -807.86k | 2.85m | -- | -- | 55.62 | -- | -- | -0.652 | -0.652 | 0.00 | 0.0331 | 0.00 | -- | -- | -- | -133.71 | -56.57 | -480.99 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
| Elicera Therapeutics AB | 961.36k | -1.40m | 2.85m | 2.00 | -- | 1.15 | -- | 2.97 | -0.8289 | -0.8289 | 0.5677 | 0.8291 | 0.2936 | -- | 8.13 | 5,615,030.00 | -42.88 | -40.06 | -66.66 | -49.74 | -- | -- | -146.02 | -415.41 | -- | -- | 0.00 | -- | 777.23 | -- | 15.64 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -1.53m | 2.98m | 2.00 | -- | 1.97 | -- | -- | -1.04 | -1.04 | 0.00 | 0.492 | 0.00 | -- | -- | 0.00 | -114.31 | -141.06 | -237.09 | -278.44 | -- | -- | -- | -- | -- | -10.96 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | 0.00 | -1.57m | 3.00m | 5.00 | -- | 0.8519 | -- | -- | -0.1824 | -0.355 | 0.00 | 0.3862 | 0.00 | -- | -- | 0.00 | -19.03 | -37.28 | -31.28 | -51.56 | -- | -- | -- | -2,077.34 | -- | -3.88 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| Biosenic SA | 0.00 | -19.67m | 3.05m | 12.00 | -- | -- | -- | -- | -0.1577 | -0.1577 | 0.00 | -0.1328 | 0.00 | -- | -- | 0.00 | -189.15 | -44.56 | -1,067.28 | -71.69 | -- | -- | -- | -1,782.33 | -- | -1.60 | 3.65 | -- | -100.00 | -- | 84.21 | -- | -58.68 | -- |
| Biophytis SA | 0.00 | -17.03m | 3.23m | 26.00 | -- | -- | -- | -- | -0.0164 | -0.0164 | 0.00 | -0.0037 | 0.00 | -- | -- | -- | -100.31 | -97.52 | -1,481.81 | -487.25 | -- | -- | -- | -- | -- | -12.25 | -- | -- | -- | -- | 29.69 | -- | 14.25 | -- |
| Braster SA | 302.68k | -886.95k | 3.76m | 16.00 | -- | -- | -- | 12.42 | -0.2825 | -0.2825 | 0.0561 | -0.1734 | 0.0601 | 0.0769 | 163.38 | -- | -17.61 | -29.23 | -220.50 | -50.27 | 71.16 | 68.77 | -293.04 | -1,435.54 | 0.3061 | -2.59 | 1.62 | -- | 413.76 | 41.35 | 42.87 | -- | -- | -- |
| Lipigon Pharmaceuticals AB | 1.40m | -1.04m | 3.89m | -- | -- | 1.60 | -- | 2.77 | -0.4662 | -0.4662 | 0.3201 | 0.225 | 0.7388 | -- | 14.81 | -- | -54.60 | -314.67 | -75.05 | -426.49 | -- | -- | -73.91 | -488.14 | -- | -- | 0.00 | -- | -- | 444.44 | 67.83 | -- | -- | -- |
| Oncozenge AB | 0.00 | -1.36m | 3.91m | -- | -- | 2.45 | -- | -- | -1.36 | -1.36 | 0.00 | 1.59 | 0.00 | -- | -- | -- | -55.57 | -- | -60.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 65.91 | -- | -- | -- |
| NextCell Pharma AB | 1.05m | -3.48m | 3.96m | -- | -- | 0.7013 | -- | 3.78 | -1.18 | -1.18 | 0.3555 | 1.92 | 0.124 | 14.66 | 6.80 | -- | -41.28 | -34.92 | -45.63 | -37.06 | 6.61 | -68.21 | -332.90 | -538.60 | 4.97 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
| IntegraGen SA | 12.49m | -123.83k | 3.97m | 57.00 | -- | 2.04 | 48.72 | 0.3178 | -0.0179 | -0.0179 | 1.88 | 0.2887 | 1.24 | 9.09 | 3.09 | 198,274.60 | -1.23 | -4.20 | -4.00 | -9.43 | 64.75 | 64.10 | -0.9913 | -3.67 | 1.23 | -- | 0.418 | -- | 16.27 | 16.08 | -122.78 | -- | -- | -- |
Data as of Apr 26 2024. Currency figures normalised to Biosenic SA's reporting currency: Euro EUR
0.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Tocqueville Finance SAas of 31 Jan 2024 | 52.60k | 0.03% |
| Aviva Investors Global Services Ltd.as of 15 Apr 2021 | 46.52k | 0.02% |
| FV Frankfurter Verm�gen AGas of 31 Aug 2022 | 20.00k | 0.01% |
| Iris Finance SAas of 31 Dec 2018 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2018 - 29 Feb 2024Source: FactSet Research Systems Inc.
